Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
Sabino De Placido, Antonio Giordano(University of Siena), Agnese Montanino(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Roberta Maria Pennacchio(University of Naples Federico II), Valeria Forestieri(University of Naples Federico II), Gennaro Limite(University of Naples Federico II), Mario Giuliano(Regione Campania), Lucrezia Silvestro(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Emilia Montagna, Giuseppe Cancello, Rossella Lauria, Diego D’Agostino(University of Naples Federico II), Angela Espósito(European Institute of Oncology), Carmen Criscitiello(University of Milan), Angelo Raffaele Bianco(University of Naples Federico II)
Cited by 413
Related Papers
Curcumin and Cancer
|Nutrients|2019|977
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Role of p53 in the Regulation of Cellular Senescence
|Biomolecules|2020|605